ANI Pharmaceuticals held its 2024 Annual Meeting of Stockholders and approved the Amended and Restated 2022 Stock Incentive Plan. Directors were elected, the appointment of the independent registered public accounting firm was ratified, the compensation of named executive officers was approved, and the Amended 2022 Stock Plan was approved.